Literature DB >> 29321328

Activities of Thrombin and Factor Xa Are Essential for Replication of Hepatitis E Virus and Are Possibly Implicated in ORF1 Polyprotein Processing.

Gayatri D Kanade1,2, Kunal D Pingale1,2, Yogesh A Karpe3,2.   

Abstract

Hepatitis E virus (HEV) is a clinically important positive-sense RNA virus. The ORF1 of HEV encodes a nonstructural polyprotein of 1,693 amino acids. It is not clear whether the ORF1 polyprotein (pORF1) is processed into distinct enzymatic domains. Many researchers have attempted to understand the mechanisms of pORF1 processing. However, these studies gave various results and could never convincingly establish the mechanism of pORF1 processing. In this study, we demonstrated the possible role of thrombin and factor Xa in pORF1 processing. We observed that the HEV pORF1 polyprotein bears conserved cleavage sites of thrombin and factor Xa. Using a reverse genetics approach, we demonstrated that an HEV replicon having mutations in the cleavage sites of either thrombin or factor Xa could not replicate efficiently in cell culture. Further, we demonstrated in vitro processing when we incubated recombinant pORF1 fragments with thrombin, and we observed the processing of pORF1 polyprotein. The treatment of a liver cell line with a serine protease inhibitor as well as small interfering RNA (siRNA) knockdown of thrombin and factor Xa resulted in significant reduction in the replication of HEV. Thrombin and factor Xa have been well studied for their roles in blood clotting. Both of these proteins are believed to be present in the active form in the blood plasma. Interestingly, in this report, we demonstrated the presence of biologically active thrombin and factor Xa in a liver cell line. The results suggest that factor Xa and thrombin are essential for the replication of HEV and may be involved in pORF1 polyprotein processing of HEV.IMPORTANCE Hepatitis E virus (HEV) causes a liver disorder called hepatitis in humans, which is mostly an acute and self-limiting infection in adults. A high mortality rate of about 30% is observed in HEV-infected pregnant women in developing countries. There is no convincing opinion about HEV ORF1 polyprotein processing owing to the variability of study results obtained so far. HEV pORF1 has cleavage sites for two host cellular serine proteases, thrombin and factor Xa, that are conserved among HEV genotypes. For the first time, this study demonstrated that thrombin and factor Xa cleavage sites on HEV pORF1 are obligatory for HEV replication. Intracellular biochemical activities of the said serine proteases are also essential for efficient HEV replication in cell culture and must be involved in pORF1 processing. This study sheds light on the presence and roles of clotting factors with respect to virus replication in the cells.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  factor Xa; hepatitis E virus; polyprotein processing; positive-stranded RNA virus; thrombin

Mesh:

Substances:

Year:  2018        PMID: 29321328      PMCID: PMC5827406          DOI: 10.1128/JVI.01853-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Virus-specific mRNA capping enzyme encoded by hepatitis E virus.

Authors:  J Magden; N Takeda; T Li; P Auvinen; T Ahola; T Miyamura; A Merits; L Kääriäinen
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

Authors:  M Zafrullah; M H Ozdener; S K Panda; S Jameel
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Synthesis and processing of Sindbis virus nonstructural proteins in vitro.

Authors:  P L Collins; F J Fuller; P I Marcus; L E Hightower; L A Ball
Journal:  Virology       Date:  1982-04-30       Impact factor: 3.616

4.  Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease.

Authors:  Yogesh A Karpe; Kavita S Lole
Journal:  J Gen Virol       Date:  2011-06-08       Impact factor: 3.891

5.  The 3' end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp).

Authors:  S Agrawal; D Gupta; S K Panda
Journal:  Virology       Date:  2001-03-30       Impact factor: 3.616

6.  Early secretory pathway localization and lack of processing for hepatitis E virus replication protein pORF1.

Authors:  Julia Perttilä; Pirjo Spuul; Tero Ahola
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

7.  Binding and internalization of thrombin by normal and transformed chick cells.

Authors:  B R Zetter; L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

8.  Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses.

Authors:  E V Koonin; A E Gorbalenya; M A Purdy; M N Rozanov; G R Reyes; D W Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

9.  The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics.

Authors:  Harilakshmi Kannan; Sumin Fan; Deendayal Patel; Ioannis Bossis; Yan-Jin Zhang
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

Review 10.  Hepatitis E virus: animal reservoirs and zoonotic risk.

Authors:  X J Meng
Journal:  Vet Microbiol       Date:  2009-03-20       Impact factor: 3.293

View more
  15 in total

Review 1.  Life cycle and morphogenesis of the hepatitis E virus.

Authors:  Kiyoshi Himmelsbach; Daniela Bender; Eberhard Hildt
Journal:  Emerg Microbes Infect       Date:  2018-11-29       Impact factor: 7.163

Review 2.  Hepatitis E Virus Replication.

Authors:  Robert LeDesma; Ila Nimgaonkar; Alexander Ploss
Journal:  Viruses       Date:  2019-08-06       Impact factor: 5.048

3.  The Amino-Terminal Region of Hepatitis E Virus ORF1 Containing a Methyltransferase (Met) and a Papain-Like Cysteine Protease (PCP) Domain Counteracts Type I Interferon Response.

Authors:  Eugénie Bagdassarian; Virginie Doceul; Marie Pellerin; Antonin Demange; Léa Meyer; Nolwenn Jouvenet; Nicole Pavio
Journal:  Viruses       Date:  2018-12-18       Impact factor: 5.048

Review 4.  Hepatitis E Virus Drug Development.

Authors:  Volker Kinast; Thomas L Burkard; Daniel Todt; Eike Steinmann
Journal:  Viruses       Date:  2019-05-28       Impact factor: 5.048

Review 5.  On the Host Side of the Hepatitis E Virus Life Cycle.

Authors:  Noémie Oechslin; Darius Moradpour; Jérôme Gouttenoire
Journal:  Cells       Date:  2020-05-22       Impact factor: 6.600

6.  Hepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by in silico Modeling and Cell-Free Inhibition Assays.

Authors:  Shweta Saraswat; Meenakshi Chaudhary; Deepak Sehgal
Journal:  Front Cell Infect Microbiol       Date:  2020-01-23       Impact factor: 5.293

Review 7.  Virus-Host Cell Interplay during Hepatitis E Virus Infection.

Authors:  Michael H Wißing; Yannick Brüggemann; Eike Steinmann; Daniel Todt
Journal:  Trends Microbiol       Date:  2020-08-19       Impact factor: 18.230

8.  Characterization of a Cell Culture System of Persistent Hepatitis E Virus Infection in the Human HepaRG Hepatic Cell Line.

Authors:  Marie Pellerin; Edouard Hirchaud; Yannick Blanchard; Nicole Pavio; Virginie Doceul
Journal:  Viruses       Date:  2021-03-04       Impact factor: 5.048

Review 9.  Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections.

Authors:  Rami A Al-Horani
Journal:  Am J Cardiovasc Drugs       Date:  2020-12       Impact factor: 3.283

Review 10.  Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19.

Authors:  Kholoud F Aliter; Rami A Al-Horani
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-01       Impact factor: 3.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.